IQVIA Holdings Inc (IQV) Stock Analysis
$IQV · HEALTHCARE · DIAGNOSTICS & RESEARCH
IQVIA Holdings (IQV), a DIAGNOSTICS & RESEARCH company, has a market capitalization of about $28.23B and trades at 21.0x trailing earnings.
Price
$169.12
Market cap
$28.23B
P/E ratio
21.0x
Dividend yield
—
About IQVIA Holdings Inc
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
How StockWorthy values IQV
StockWorthy forecasts IQVIA Holdings Inc's revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from IQV's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.
Related stocks
See IQV's Fair Value
Create a free account to view IQVIA Holdings Inc's base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.